HCA Healthcare price target lowered to $392 from $396 at Barclays
The Fly

HCA Healthcare price target lowered to $392 from $396 at Barclays

Barclays lowered the firm’s price target on HCA Healthcare (HCA) to $392 from $396 and keeps an Overweight rating on the shares. While 2024 was a “particularly great” year for hospitals, 2025 is also attractive and there is earnings upside for both HCA and Tenet with reasonable organic growth assumptions, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App